[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 21, Issue 4 (winter 2012) ::
MEDICAL SCIENCES 2012, 21(4): 244-250 Back to browse issues page
Optimization of human immunodeficiency virus type one replication assay using single cycle replicable virions
Rezvan Zabihollahi * 1, Maryam Nourmohammadi 2, Rouhollah Vahabpour 3, Seyed Mehdi Sadat 3, Azar Farhang Esfahani 4, Rahele Namazi 2, Mohamad Reza Aghasadeghi 5, Mansoor Salehi 6, Seyed Davar Siadat 7, Saied Reza nadaf
1- Medical student, Department of Hepatitis and AIDS, Pasteur institute of Iran, Tehran, Iran , Rezvan_z_m@yahoo.com
2- BSc, Department of Medical Genetics, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3- MSc, Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran
4- MSc Student, Young Researchers Club, Islamic Azad University, Falavarjan branch, Falavarjan, Iran
5- Assistant Professor, Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran
6- Associate Professor, Department of Medical Genetics, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
7- Assistant Professor, Department of Parasitology, Pasteur Institute of Iran, Tehran, Iran
Abstract:   (12613 Views)
Background: HIV virions with replication capacity are needed for HIV researches, like investigating for new anti HIV agents. Here HIV-1 replication assay was optimized with HIV-1 single cycle replicable (SCR) virions to improve biological safety condition.
Materials and methods: pSPAX2, pmzNL4-3 and pMD2G plasmids were co-transfected to the HEK293T by using polyfect reagent to produce the SCR HIV-1 virions. Virions were quantified using capture ELISA P24. Different MOI of SCR virions were used for infecting of Target cells (HEK) and the load of the supernatant P24 was monitored days after infection. Single cycle replication assay (SCRA) was developed using kinetic studies data.
Results: The P24 load of the infected cells supernatant has linear relation to the beginning infectious MOI. 24 hours post infection with HIV-1 SCR virions the viral particle production was detectable. The highest load of P24 in infected cells supernatant was detected 48 hours after infection. Using this developed method, the 50 and 95 percent inhibitory concentration of (IC95 and IC50) Indinavir and Nevirapine were calculated as 25nM and 50nM.
Conclusion: In this study, using SCR HIV-1 virions the SCRA was developed. SCR HIV-1 virions are replicable only for one cycle and this improves the safety of developed assays. The accuracy of assay was examined by quantifying the anti HIV-1 potential of two commercial anti-AIDS drugs and the calculated activity for test agents was equal to previously known amounts.
Keywords: HIV, SCR, Replication assay, Biological safety, Anti-HIV agent
Full-Text [PDF 376 kb]   (1413 Downloads)    
Type of Study: Survey/Cross Sectional/Descriptive | Subject: Genetic
Received: 2012/02/14
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA code


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zabihollahi R, Nourmohammadi M, Vahabpour R, Sadat S M, Farhang Esfahani A, Namazi R, et al . Optimization of human immunodeficiency virus type one replication assay using single cycle replicable virions. MEDICAL SCIENCES. 2012; 21 (4) :244-250
URL: http://iau-tmuj.ir/article-1-522-en.html


Volume 21, Issue 4 (winter 2012) Back to browse issues page
فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران Medical Science Journal of Islamic Azad Univesity - Tehran Medical Branch
Persian site map - English site map - Created in 0.05 seconds with 31 queries by YEKTAWEB 3781